Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Gordon

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Archives of General Psychiatry|June 9, 2005
Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorderElaine K Green, Rachel Raybould, Stuart Macgregor, et al.
Cell Chemical Biology|June 21, 2016
Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis InhibitorsSarah Schmidt Grant, Samantha Wellington, Tomohiko Kawate, et al.
JAMA Psychiatry|August 31, 2022
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar DisorderAlexander L Richards, Alastair Cardno, Gordon Harold, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 30, 2017
Genome-wide significant locus for Research Diagnostic Criteria Schizoaffective Disorder Bipolar typeElaine K Green, Arianna Di Florio, Liz Forty, et al.
JAMA Psychiatry|November 22, 2019
Comparison of Genetic Liability for Sleep Traits Among Individuals With Bipolar Disorder I or II and Control ParticipantsKatie J S Lewis, Alexander Richards, Robert Karlsson, et al.
European Urology Oncology|June 25, 2026
Genomic Prostate Score for Identifying Biologically Low-risk Disease in Patients with Prostate Cancer Undergoing Active Surveillance, Surgery, or RadiotherapyNikita Sushentsev, Richard Colling, Renuka Teague, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 29, 2010
Variation at the GABAA receptor gene, Rho 1 (GABRR1) associated with susceptibility to bipolar schizoaffective disorderElaine K Green, Detelina Grozeva, Valentina Moskvina, et al.
JAMA Psychiatry|November 24, 2017
Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar DisorderJudith Allardyce, Ganna Leonenko, Marian Hamshere, et al.
Biological Psychiatry|January 29, 2019
Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective CasesAlexander W Charney, Eli A Stahl, Elaine K Green, et al.
Molecular Psychiatry|October 28, 2015
Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorderJ Song, S E Bergen, A Di Florio, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Archives of General Psychiatry|June 9, 2005
Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorderElaine K Green, Rachel Raybould, Stuart Macgregor, et al.
Cell Chemical Biology|June 21, 2016
Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis InhibitorsSarah Schmidt Grant, Samantha Wellington, Tomohiko Kawate, et al.
JAMA Psychiatry|August 31, 2022
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar DisorderAlexander L Richards, Alastair Cardno, Gordon Harold, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 30, 2017
Genome-wide significant locus for Research Diagnostic Criteria Schizoaffective Disorder Bipolar typeElaine K Green, Arianna Di Florio, Liz Forty, et al.
JAMA Psychiatry|November 22, 2019
Comparison of Genetic Liability for Sleep Traits Among Individuals With Bipolar Disorder I or II and Control ParticipantsKatie J S Lewis, Alexander Richards, Robert Karlsson, et al.
European Urology Oncology|June 25, 2026
Genomic Prostate Score for Identifying Biologically Low-risk Disease in Patients with Prostate Cancer Undergoing Active Surveillance, Surgery, or RadiotherapyNikita Sushentsev, Richard Colling, Renuka Teague, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 29, 2010
Variation at the GABAA receptor gene, Rho 1 (GABRR1) associated with susceptibility to bipolar schizoaffective disorderElaine K Green, Detelina Grozeva, Valentina Moskvina, et al.
JAMA Psychiatry|November 24, 2017
Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar DisorderJudith Allardyce, Ganna Leonenko, Marian Hamshere, et al.
Biological Psychiatry|January 29, 2019
Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective CasesAlexander W Charney, Eli A Stahl, Elaine K Green, et al.
Molecular Psychiatry|October 28, 2015
Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorderJ Song, S E Bergen, A Di Florio, et al.
Pageof 9